Genentech
AVASTIN
Manufacturer:
Genentech
Name:
AVASTIN
HCPCS Code Descriptor:
Injection, bevacizumab, 10 mg
Category:
J Code
HCPCS:
J9035
NDC(s):
50242-0060-01, 50242-0061-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
AVASTIN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9035 is aligned to the drug AVASTIN.
Avastin works in combination with certain chemotherapies and is used to prevent tumor growth in various types of cancer. By blocking the growth of new blood vessels that cancer cells depend on, Avastin should stop cancer cells from growing and reproducing. As of 2023, there are multiple biosimilar drugs available for Avastin including Mvasi (Q5107), Riabni (Q5123), and Zirabev (Q5118).
Access Pricing and More By Registering
HCPCS Added Date:
1/1/05
HCPCS Effective Date:
1/1/05
HCPCS Short Description:
Bevacizumab injection
Billing and Coding Guide:
Not Found
Patient Assistance:
https://www.avastin.com/hcp/contact-a-representative.html
https://www.avastin.com/patient/financial-resources.html